ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 219 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $23,565,000 | +43.0% | 345,523 | +32.0% | 0.74% | -13.6% |
Q2 2020 | $16,481,000 | -47.6% | 261,808 | -65.1% | 0.86% | -66.9% |
Q1 2020 | $31,467,000 | -35.3% | 749,217 | -30.0% | 2.58% | +11.6% |
Q4 2019 | $48,627,000 | -53.2% | 1,070,616 | -52.9% | 2.32% | -24.6% |
Q3 2019 | $103,968,000 | -3.0% | 2,271,536 | +24.2% | 3.07% | +50.8% |
Q2 2019 | $107,198,000 | -26.5% | 1,828,378 | -43.8% | 2.04% | -36.9% |
Q1 2019 | $145,932,000 | +24.3% | 3,255,230 | +8.0% | 3.22% | +3.4% |
Q4 2018 | $117,421,000 | -6.5% | 3,014,672 | +10.4% | 3.12% | +69.6% |
Q3 2018 | $125,614,000 | +140.7% | 2,729,555 | +128.1% | 1.84% | +125.2% |
Q2 2018 | $52,184,000 | – | 1,196,891 | – | 0.82% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |